HOME >> MEDICINE >> NEWS
Norwegian torpedo boat service associated with increased risk of birth defects

Military service aboard a Norwegian missile torpedo boat was associated with a signficantly increased risk of having children with birth defects or who were stillborn, reveals research in Occupational and Environmental Medicine.

The findings are based on the health and family data of more than 2000 current employees of the Royal Norwegian Navy.

In common with other ships of its class, the vessel, which had been deployed between 1971 and 1995, was equipped with high, very high, and ultra high frequency transmitters.

Between 1987 and 1994, the ship was additionally equipped with a 750 watt high frequency transmitter, and emitted signals over protracted periods of time during the course of "electronic warfare."

Sixty two employees had served aboard the torpedo boat during the 1990s, and 50 became parents to 117 children of whom 114 were included in the study.

Of these children, 87 were classified as having been conceived during or after employment aboard ship.

Eight of these children had been born with birth defects and six had been stillborn. All the children with congenital anomalies had been born to male employees.

The rates of birth defects and stillbirths among these children were four times as high as among those whose fahers had not served aboard this torpedo boat.

There were no significant differences in lifestyle, alcohol, or cigarette consumption between the two groups of employees.

An accompanying editorial is quick to point out that an association does not imply a causal effect, particularly as there is as yet no obvious biological explanation for the findings.

However, the editorial calls for further research into the reproductive histories of active naval personnel, noting that there has been relatively little research into the possible impact of electromagnetic fields on birth defects.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ Specialty Journals
16-Jan-2006


Page: 1

Related medicine news :

1. Norwegian government handles research fraud
2. More than 50% of surveyed Norwegian doctors self-prescribe
3. Pediatricians rarely provide translation services for patients with little English proficiency
4. Teenagers with retail, service jobs at risk of injury, robberies, sleep deprivation
5. Should Muslims have faith-based health services?
6. Ethnic disparities in alcohol services: financial and logistical barriers are key
7. UCLA study finds a need for services that help homeless youth obtain health insurance
8. Extra payments to Medicare Advantage plans totaled $5.2 billion over fee-for-service costs in 2005
9. Increased patient demand for prostate test has serious implications for cancer services
10. DTI research and development scoreboard reveals extent of R&D in services sector
11. The Vicious Triangle affecting productivity in our public services

Post Your Comments:
(Date:8/31/2015)... ... August 31, 2015 , ... ... at Monmouth, was one of the first doctors in the area to perform ... new approach have been impressive: faster recovery, decreased immediate and long-term pain, and ...
(Date:8/31/2015)... ... ... Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an ... from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters ... senior year. He was inducted into the National Honor Society as a sophomore, was ...
(Date:8/31/2015)... ... 31, 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can ... that contains a mathematical formula for modifying an image. The LUT changes every pixel's color ... LUT files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare meet the ... costs? , In a commentary for The American Journal of Managed Care ... “clinical efficacy,” which would bind parties together in agreements to intervene at the ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of diseases of the central nervous system ... submission has passed review by the US Food and ... 1 clinical trial in patients with metastatic colon cancer ... 31 December 2015. Bionomics, CEO & Managing ...
(Date:8/30/2015)... ANDOVER, Massachusetts y LONDRES, August 30, 2015 ... conectada ofrece una visión holística de l ... de todo el trayecto   ... anunciado hoy el debut europeo de IntelliSpace Cardiovascular ... información que ofrece sofisticadas herramientas para acceder, analizar y ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
Cached News: